Use of dipeptidyl peptidase‐4 inhibitors and prognosis of <scp>COVID</scp> ‐19 in hospitalized patients with type 2 diabetes: A propensity score analysis from the <scp>CORONADO</scp> studyRonan Roussel, Patrice Darmon, Matthieu Pichelin et al.|Diabetes Obesity and Metabolism|2021Cited by 36